Cardiometabolic Disorders Cardiometabolic disorders are a collection of interrelated conditions, mainly dyslipidemia, insulin resistance, impaired glucose tolerance, hypertension, and central adiposity (Kirk and Klein, 2009)
With BPC-157, the benefits are unproven and the risks unknown a scenario that challenges the ethical boundaries of clinical practice
Specific peptides may also help boost the release of hormones known to stimulate muscle growth, body fat loss, and exercise performance and recovery
Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy
2 Established in 2003 and revised in 2018, the Rotterdam criteria are the standard diagnostic guidelines for PCOS
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors